Thursday, March 31, 2005
Another case of PML hits the MS drug Tysabri
PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.
PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.
Posted by Kevin |
link
| Comments (0)
| 
Comments: Post a Comment
